SRPT Sarepta Therapeutics Inc

Sarepta Therapeutics Inc is a biotechnology company. It uses proprietary RNA-targeted technology platforms for developing pharmaceutical products to address serious diseases.

$70.43  -1.03 (-1.44%)
As of 04/09/2021 15:59:53 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/02/2003
Outstanding shares:  79,420,643
Average volume:  1,008,294
Market cap:   $5,602,332,157
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    803607100
ISIN:        US8036071004
Sedol:      B8DPDT7
Valuation   (See tab for details)
PE ratio:   -10.11
PB ratio:   7.35
PS ratio:   10.37
Return on equity:   -72.74%
Net income %:   -102.60%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy